Compugen (CGEN) Liabilities from Discontinued Operations (2009)

Compugen (CGEN) reported Liabilities from Discontinued Operations of 12000.0 for Q2 2009, little changed sequentially from 12000.0 in Q1 2009.

Compugen (CGEN) Liabilities from Discontinued Operations (2009) Analysis & Trends

Compugen (CGEN) has 1 years of Liabilities from Discontinued Operations data on file, last reported at 12000.0 in Q2 2009.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Compugen	221.26 Mn	129.51 Mn	352,000.00

Download Data